297 related articles for article (PubMed ID: 25945832)
1. Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Bhatia M; Tonissen KF
Oncotarget; 2015 Jun; 6(17):15410-24. PubMed ID: 25945832
[TBL] [Abstract][Full Text] [Related]
2. TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Cell Cycle; 2016; 15(4):559-72. PubMed ID: 26743692
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress.
Park WH
Oncol Rep; 2020 Jan; 43(1):358-367. PubMed ID: 31789420
[TBL] [Abstract][Full Text] [Related]
4. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
Du Y; Zhang H; Lu J; Holmgren A
J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
[TBL] [Abstract][Full Text] [Related]
5. The thioredoxin system in breast cancer cell invasion and migration.
Bhatia M; McGrath KL; Di Trapani G; Charoentong P; Shah F; King MM; Clarke FM; Tonissen KF
Redox Biol; 2016 Aug; 8():68-78. PubMed ID: 26760912
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
[TBL] [Abstract][Full Text] [Related]
8. Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo.
Lin QD; Liu LN; Liu XY; Yan Y; Fang BJ; Zhang YL; Zhou J; Li YF; Zuo WL; Song YP
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1283-1292. PubMed ID: 35253185
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma.
Zheng Z; Fan S; Zheng J; Huang W; Gasparetto C; Chao NJ; Hu J; Kang Y
J Hematol Oncol; 2018 Feb; 11(1):29. PubMed ID: 29482577
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation.
Watson WH; Heilman JM; Hughes LL; Spielberger JC
Biochem Biophys Res Commun; 2008 Apr; 368(3):832-6. PubMed ID: 18267104
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H
Dagnell M; Pace PE; Cheng Q; Frijhoff J; Östman A; Arnér ESJ; Hampton MB; Winterbourn CC
J Biol Chem; 2017 Sep; 292(35):14371-14380. PubMed ID: 28684416
[TBL] [Abstract][Full Text] [Related]
12. Abrogated thioredoxin system causes increased sensitivity to TNF-α-induced apoptosis via enrichment of p-ERK 1/2 in the nucleus.
Yoo MH; Carlson BA; Gladyshev VN; Hatfield DL
PLoS One; 2013; 8(9):e71427. PubMed ID: 24039713
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of the thioredoxin and glutaredoxin systems in dopamine-induced cell death.
Arodin L; Miranda-Vizuete A; Swoboda P; Fernandes AP
Free Radic Biol Med; 2014 Aug; 73():328-36. PubMed ID: 24863694
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer.
Samaranayake GJ; Troccoli CI; Huynh M; Lyles RDZ; Kage K; Win A; Lakshmanan V; Kwon D; Ban Y; Chen SX; Zarco ER; Jorda M; Burnstein KL; Rai P
Nat Commun; 2017 Oct; 8(1):1204. PubMed ID: 29089489
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase.
Pader I; Sengupta R; Cebula M; Xu J; Lundberg JO; Holmgren A; Johansson K; Arnér ES
Proc Natl Acad Sci U S A; 2014 May; 111(19):6964-9. PubMed ID: 24778250
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin-mimetic peptides (TXM) reverse auranofin induced apoptosis and restore insulin secretion in insulinoma cells.
Cohen-Kutner M; Khomsky L; Trus M; Aisner Y; Niv MY; Benhar M; Atlas D
Biochem Pharmacol; 2013 Apr; 85(7):977-90. PubMed ID: 23327993
[TBL] [Abstract][Full Text] [Related]
17. The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells.
Wangpaichitr M; Sullivan EJ; Theodoropoulos G; Wu C; You M; Feun LG; Lampidis TJ; Kuo MT; Savaraj N
Mol Cancer Ther; 2012 Mar; 11(3):604-15. PubMed ID: 22248473
[TBL] [Abstract][Full Text] [Related]
18. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
19. Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.
Sachweh MC; Stafford WC; Drummond CJ; McCarthy AR; Higgins M; Campbell J; Brodin B; Arnér ES; Laín S
Oncotarget; 2015 Jun; 6(18):16488-506. PubMed ID: 26029997
[TBL] [Abstract][Full Text] [Related]
20. Annatto constituent cis-bixin has selective antimyeloma effects mediated by oxidative stress and associated with inhibition of thioredoxin and thioredoxin reductase.
Tibodeau JD; Isham CR; Bible KC
Antioxid Redox Signal; 2010 Oct; 13(7):987-97. PubMed ID: 20170403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
